...
首页> 外文期刊>Journal of receptor and signal transduction research >Mining human genome for novel purinergic P2Y receptors: A sequence analysis and molecular modeling approach
【24h】

Mining human genome for novel purinergic P2Y receptors: A sequence analysis and molecular modeling approach

机译:挖掘人类基因组的新型嘌呤P2Y受体:序列分析和分子建模方法

获取原文
获取原文并翻译 | 示例
           

摘要

The purinergic P2Y receptors are G-protein coupled receptors (GPCRs) that control many physiological processes by mediating cellular responses to purines, pyrimidines and their analogues. They can be used as potential therapeutic targets in a variety of disease conditions. Therefore, it is critical to identify new members of this family of receptors from the human genome and characterize them for their role in health and disease. In the present work, molecular modeling was carried out for the 21 known P2Y receptors. Binding site analysis was done on the basis of docking and site-directed mutagenesis data. Thus, conserved features of P2Y receptors could be formulated. These features can be used to determine the purinergic nature of potential P2Y receptors in the human genome. We applied this knowledge to human genome GPCR sequences found by sensitive sequence search techniques and identified two orphan receptors, namely GPR34 and GP171 that have all the necessary conserved features of P2Y receptors.
机译:嘌呤能P2Y受体是G蛋白偶联受体(GPCR),可通过介导对嘌呤,嘧啶及其类似物的细胞应答来控制许多生理过程。它们可以在多种疾病中用作潜在的治疗靶标。因此,从人类基因组中鉴定该受体家族的新成员并表征它们在健康和疾病中的作用至关重要。在目前的工作中,对21种已知的P2Y受体进行了分子建模。结合位点分析是基于对接和定点诱变数据进行的。因此,可以制定P2Y受体的保守特征。这些特征可用于确定人类基因组中潜在P2Y受体的嘌呤能性质。我们将此知识应用于通过敏感序列搜索技术发现的人类基因组GPCR序列,并鉴定出两个孤儿受体,即GPR34和GP171,它们具有P2Y受体所有必要的保守特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号